Business

Victory Square Technologies Reports Q3 2025 Financial Results & Provides Corporate Update

Vancouver, British Columbia--(Newsfile Corp. - December 1, 2025) - Victory Square Technologies Inc. (CSE: VST) (FSE: 6F6) (OTC Pink: VSQTF) ("Victory Square" or the "Company") today released its financial results for the three and nine months ended September 30, 2025, and provided a comprehensive update on key developments across its digital health, biotech, pet wellness, climate tech, and immersive technology platforms.The Company's complete financial statements and Management Discussion &...

articleVictory Square Technologies IncDecember 1, 202511/company/victory-square-technologies-inc/news/victory-square-technologies-reports-q3-032800468
Victory Square Technologies Reports Q3 2025 Financial Results & Provides Corporate Update

About this update from Victory Square Technologies Inc

[{"type":"text","content":"Vancouver, British Columbia--(Newsfile Corp. - December 1, 2025) - Victory Square Technologies Inc. (CSE: VST) (FSE: 6F6) (OTC Pink: VSQTF) ("Victory Square" or the "Company") today released its financial results for the three and nine months ended September 30, 2025, and provided a comprehensive update on key developments across its digital health, biotech, pet wellness, climate tech, and immersive technology platforms.","length":444,"tagName":"p"},{"type":"text","content":"The Company's complete financial statements and Management Discussion & Analysis ("MD&A") for Q3 2025 are available on SEDAR+ at www.sedarplus.ca.","length":168,"tagName":"p"},{"type":"text","content":"Q3 2025 Financial Highlights","length":28,"tagName":"p"},{"type":"text","content":"Three months ended September 30, 2025:","length":38,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Adjusted Revenue: $12.83 million","length":32,"tagName":"p"}]},{"val":[{"type":"text","content":"GAAP Revenue: $10.52 million","length":28,"tagName":"p"}]},{"val":[{"type":"text","content":"Gross Margin: $2.33 million","length":27,"tagName":"p"}]},{"val":[{"type":"text","content":"Adjusted EBITDA: $1.26 million","length":30,"tagName":"p"}]},{"val":[{"type":"text","content":"Cash & Marketable Securities: $25.91 million","length":48,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":165,"olType":false},{"type":"text","content":"Nine months ended September 30, 2025:","length":37,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Adjusted Revenue: $26.71 million","length":32,"tagName":"p"}]},{"val":[{"type":"text","content":"GAAP Revenue: $20.44 million","length":28,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":60,"olType":false},{"type":"text","content":""Q3 was another quarter of focused execution across our portfolio," said Shafin Diamond Tejani, CEO of Victory Square. "Hydreight continued its national expansion in digital health, Insu progressed toward first-in-human oral insulin studies, Pawsible launched its $10 million fund and studio, and XR Immersive Tech deepened its move into health-related IP. These developments reinforce our long-term strategy and the core verticals where we see significant opportunity for value creation."","length":5...

More updates from Victory Square Technologies Inc

Victory SquareThe Companydigital healthVictory Square Technologies Inc.Deloitte Technology Fast 50